Rather than treating individual risk factors in isolation, this triple agonist peptide addresses the underlying metabolic dysfunction that drives cardiovascular disease
Below are some of the most common questions we hear and how InjectCos medical weight loss program in Florida is structured to address them
(Wegovy or Zepbound only) Pregnancy and breastfeeding: Speak with your provider if you are or plan to be pregnant or breastfeeding, as these GLP-1 agonists should only be used during pregnancy or breastfeeding if the potential benefit outweighs potential risk to the fetus or breastfed infant
Semaglutide, dulaglutide, and liraglutide are established alternatives, though they too can cause gastrointestinal side effects
Proactive monitoring becomes part of responsible GLP-1 patient care
Branded pens require refrigeration at 36 to 46 F until use, and tolerate room temperature for up to 21 days